Reza Vali1, Hasan Ghandourah2, Martin Charron3, Kimiya V Nezhad1, Yusuaf Omarkhail1, Afsoon Khazaee1, Amer Shammas1, Sharon D Dell2,4. 1. Department of Medical Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada. 2. Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada. 3. Brambton Nuclear Service, Brambton, Ontario, Canada. 4. Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Abstract
INTRODUCTION: The accuracy of primary ciliary dyskinesia (PCD) diagnosis has improved but no single test is diagnostic and some cases remain unsolved. Data regarding the accuracy of pulmonary radioaerosol mucociliary clearance scan (PRMCC) for the diagnosis of PCD are limited to predominantly adults using a 24-hour test. This study was performed to determine the accuracy of a 60-minute PRMCC test for diagnosing PCD in children. METHODS: Children with suspected PCD and inconclusive clinical diagnostic testing in an expert center were selected for PRMCC testing. Nebulized 99m Tc sulfur colloid was inhaled and dynamic imaging acquired for 60 to 120 minutes. Two independent radiologists blinded to the clinical diagnosis and health records overread PRMCC studies. The PRMCC result was compared with the reference standard diagnosis of PCD made by two physicians using the cumulative health record, blinded to PRMCC results. RESULTS: From 2008 to 2018, 57 patients (6-17 years) participated, of which 16 met criteria for the reference diagnosis of PCD. The PRMCC test was conclusive in 54 patients (94.7%) and had a sensitivity of 100% (95% confidence interval [CI] = 78.2-100), specificity of 85.7% (95% CI = 69.7-95.2), positive predictive value of 75% (95% CI = 57.1-87.1), negative predictive value of 100% (95% CI = 90.2-100), and accuracy of 90% (95% CI = 78.2-96.7). CONCLUSION: The 60-minute PRMCC test is noninvasive and feasible in children with a high negative predictive value for PCD. It may be a helpful adjunctive test to rule out PCD when clinical suspicion remains after guideline recommended first-line clinical testing.
INTRODUCTION: The accuracy of primary ciliary dyskinesia (PCD) diagnosis has improved but no single test is diagnostic and some cases remain unsolved. Data regarding the accuracy of pulmonary radioaerosol mucociliary clearance scan (PRMCC) for the diagnosis of PCD are limited to predominantly adults using a 24-hour test. This study was performed to determine the accuracy of a 60-minute PRMCC test for diagnosing PCD in children. METHODS:Children with suspected PCD and inconclusive clinical diagnostic testing in an expert center were selected for PRMCC testing. Nebulized 99m Tcsulfur colloid was inhaled and dynamic imaging acquired for 60 to 120 minutes. Two independent radiologists blinded to the clinical diagnosis and health records overread PRMCC studies. The PRMCC result was compared with the reference standard diagnosis of PCD made by two physicians using the cumulative health record, blinded to PRMCC results. RESULTS: From 2008 to 2018, 57 patients (6-17 years) participated, of which 16 met criteria for the reference diagnosis of PCD. The PRMCC test was conclusive in 54 patients (94.7%) and had a sensitivity of 100% (95% confidence interval [CI] = 78.2-100), specificity of 85.7% (95% CI = 69.7-95.2), positive predictive value of 75% (95% CI = 57.1-87.1), negative predictive value of 100% (95% CI = 90.2-100), and accuracy of 90% (95% CI = 78.2-96.7). CONCLUSION: The 60-minute PRMCC test is noninvasive and feasible in children with a high negative predictive value for PCD. It may be a helpful adjunctive test to rule out PCD when clinical suspicion remains after guideline recommended first-line clinical testing.
Authors: Margaret W Leigh; Milan J Hazucha; Kunal K Chawla; Brock R Baker; Adam J Shapiro; David E Brown; Lisa M Lavange; Bethany J Horton; Bahjat Qaqish; Johnny L Carson; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Jeffrey J Atkinson; Kenneth N Olivier; Scott D Sagel; Margaret Rosenfeld; Carlos Milla; Hye-Seung Lee; Jeffrey Krischer; Maimoona A Zariwala; Michael R Knowles Journal: Ann Am Thorac Soc Date: 2013-12
Authors: Woolf T Walker; Aneurin Young; Michael Bennett; Matthew Guy; Mary Carroll; John Fleming; Joy Conway; Jane S Lucas Journal: Eur Respir J Date: 2014-05-02 Impact factor: 16.671
Authors: Michael R Knowles; Margaret W Leigh; Johnny L Carson; Stephanie D Davis; Sharon D Dell; Thomas W Ferkol; Kenneth N Olivier; Scott D Sagel; Margaret Rosenfeld; Kimberlie A Burns; Susan L Minnix; Michael C Armstrong; Adriana Lori; Milan J Hazucha; Niki T Loges; Heike Olbrich; Anita Becker-Heck; Miriam Schmidts; Claudius Werner; Heymut Omran; Maimoona A Zariwala Journal: Thorax Date: 2011-12-18 Impact factor: 9.139
Authors: Panayiotis Kouis; Panayiotis K Yiallouros; Nicos Middleton; John S Evans; Kyriacos Kyriacou; Stefania I Papatheodorou Journal: Pediatr Res Date: 2016-12-09 Impact factor: 3.756
Authors: Adam J Shapiro; Stephanie D Davis; Deepika Polineni; Michele Manion; Margaret Rosenfeld; Sharon D Dell; Mark A Chilvers; Thomas W Ferkol; Maimoona A Zariwala; Scott D Sagel; Maureen Josephson; Lucy Morgan; Ozge Yilmaz; Kenneth N Olivier; Carlos Milla; Jessica E Pittman; M Leigh Anne Daniels; Marcus Herbert Jones; Ibrahim A Janahi; Stephanie M Ware; Sam J Daniel; Matthew L Cooper; Lawrence M Nogee; Billy Anton; Tori Eastvold; Lynn Ehrne; Elena Guadagno; Michael R Knowles; Margaret W Leigh; Valery Lavergne Journal: Am J Respir Crit Care Med Date: 2018-06-15 Impact factor: 21.405
Authors: Christian R Marshall; Stephen W Scherer; Maimoona A Zariwala; Lynette Lau; Tara A Paton; Tracy Stockley; Rebekah K Jobling; Peter N Ray; Michael R Knowles; David A Hall; Sharon D Dell; Raymond H Kim Journal: G3 (Bethesda) Date: 2015-07-02 Impact factor: 3.154